Skip to main content
. 2020 Oct 9;12(10):950. doi: 10.3390/pharmaceutics12100950

Figure 12.

Figure 12

Hemotoxicity assay. (A) Microscopic examination of RBC membrane damage at 2 h post-incubation with A549/T CM-HNPs at various concentrations (0.5–2.5 mg/mL). (B) Quantitative estimation of RBC membrane damage and hemoglobulin release at 2 h post-incubation. Triton-X (20%) and saline were used as positive and negative controls (PC and NC), respectively.

HHS Vulnerability Disclosure